dianhydrogalactitol has been researched along with Leukemia P388 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fox, BW; Institoris, E; Pályi, I | 1 |
| Bence, J; Gáti, E; Somfai-Relle, S | 1 |
2 other study(ies) available for dianhydrogalactitol and Leukemia P388
| Article | Year |
|---|---|
Benzamide potentiation of the cytotoxicity of bifunctional galactitol [correction of galacticol] in resistant P388 leukemia correlates with inhibition of DNA ligase II.
Topics: Animals; Benzamides; Cell Survival; Dianhydrogalactitol; DNA Ligase ATP; DNA Ligases; DNA, Neoplasm; Drug Resistance; Drug Synergism; Leukemia P388; Mice | 1992 |
Development and some characteristics of a P388 leukemia strain resistant to 1, 2:5, 6-dianhydrogalactitol.
Topics: Animals; Cell Count; Cell Survival; Cyclophosphamide; Dianhydrogalactitol; Drug Resistance; Female; Karyotyping; Leukemia P388; Leukemia, Experimental; Male; Mechlorethamine; Mice; Sugar Alcohols | 1986 |